Growth Metrics

Opus Genetics (IRD) Cash from Operations Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 37.40%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 20.11%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 16.64%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -7.60%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 34.32%
10 Opus Genetics 357.99 Mn 298.03 Mn - -51.69%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -51.69%
Dec 31, 2025 -32.79%
Sep 30, 2025 -11.03%
Jun 30, 2025 -39.18%
Mar 31, 2025 -13.39%
Dec 31, 2024 -9.62%
Sep 30, 2024 -12.70%
Jun 30, 2024 -18.99%
Mar 31, 2024 0.55%
Dec 31, 2023 44.92%
Sep 30, 2023 -41.68%
Jun 30, 2023 52.11%
Mar 31, 2023 -70.78%
Dec 31, 2022 79.58%
Sep 30, 2022 -23.67%
Jun 30, 2022 -28.23%
Mar 31, 2022 -12.10%
Dec 31, 2021 -6.91%
Sep 30, 2021 4.90%
Jun 30, 2021 0.94%
Mar 31, 2021 -1.26%
Dec 31, 2020 -5.56%
Sep 30, 2020 32.59%
Jun 30, 2020 45.85%
Mar 31, 2020 44.00%
Dec 31, 2019 74.67%
Sep 30, 2019 8.67%
Jun 30, 2019 29.07%
Mar 31, 2019 -7.26%
Dec 31, 2018 -1.58%
Sep 30, 2018 2.55%
Jun 30, 2018 -0.38%
Mar 31, 2018 -11.50%
Dec 31, 2017 -8.36%
Sep 30, 2017 -9.83%
Jun 30, 2017 -11.58%
Mar 31, 2017 -17.40%
Dec 31, 2016 12.76%
Sep 30, 2016 -22.92%
Jun 30, 2016 -26.45%
Mar 31, 2016 -31.77%
Dec 31, 2015 -60.13%
Sep 30, 2015 -39.75%
Jun 30, 2015 -30.53%
Mar 31, 2015 -28.21%
Dec 31, 2014 15.80%
Sep 30, 2014 6.29%
Jun 30, 2014 16.48%
Mar 31, 2014 -2.03%
Dec 31, 2013 2.41%
Sep 30, 2013 -1.88%